Rexford Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Buy
3,370
+3
+0.1% +$287 0.21% 140
2025
Q4
$323K Buy
3,367
+100
+3% +$9.71K 0.25% 117
2025
Q3
$311K Sell
3,267
-100
-3% -$9.19K 0.24% 121
2025
Q2
$294K Buy
+3,367
New +$286K 0.24% 127

Other funds holding MDT

Rexford Capital's MDT Position: Q1 2026 in Review

Rexford Capital increased its Medtronic (MDT) stake by 0.09% in Q1 2026, buying an estimated $287 and bringing the position to 3,370 shares worth $292K. The position accounts for 0.21% of the portfolio, ranked #140.

Rexford Capital first reported a position in MDT in Q2 2025 and has held it in 4 quarters since. The position peaked at $323K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Rexford Capital held 3,370 shares of Medtronic worth $292K as of Q1 2026.
  • Rexford Capital bought 3 Medtronic shares in Q1 2026, an estimated $287.
  • Medtronic made up 0.21% of Rexford Capital's portfolio in Q1 2026, its #140 holding.
  • Rexford Capital first reported a position in Medtronic in Q2 2025 and has held it in 4 quarters since.
  • Rexford Capital's Medtronic position peaked at $323K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.